Considering an M&A early exit for your medical device startup?
Amanda determined our medical device exit strategy and executed it skillfully to a successful outcome. As an investor, significant return on your investment is far from guaranteed but Amanda's ability to see the big picture, rally influential champions to our cause, and compel and negotiate with strategic acquirers resulting in a rewarding exit.
I wouldn't hesitate to recommend her to any medical device startup contemplating an early exit.
Rob Swart, Board Director & Investor
Who We Work With
Why Founders & Boards Work With Us
Why Most Early MedTech Exits Fall Short
Professional Services Tailored for YouText element
01.
Poor Timing
Many founders wait too long to consider an exit, missing strategic timing windows.
02.
Lack of Objectivity
Boards often lack objective, buyer-informed insight, leading to misalignment or rash decisions.
03.
Inadequate Intel
Investors may struggle to evaluate risk or identify credible opportunities in their portfolios.
As an industrial designer, I've worked with Amanda on several M&A exit projects and can attest to the accuracy of her insights into the market and potential acquirers and how that should inform initial product development or subsequent tweaks.
She recognizes that medical device startups operate on limited budgets and works well with technical teams to get the technology to just where it needs to be to attract buyer interest.
Ryan Lee, Industrial Designer
Services We Provide
Early Exit Assessment
An independent, buyer-informed assessment to help founders, boards, and investors determine whether an early exit may be viable and what timing and factors will impact a successful outcome.
Perfect for:Founders and boards who want an independent, accurate assessment to inform next steps.
Early Exit Roadmap
A structured, execution-ready plan for positioning your company for an early M&A exit when you're confident that's your next best step.It can be initiated on its own or after the Early Exit Assessment service.
Perfect for:Teams that want a clear, buyer-aligned plan to prepare for an early exit that yields optimal success.
Deal Lead Service
Hands-on leadership of a discreet, targeted exit process — from buyer outreach through deal execution. Sophisticated strategy aligned with early-stage medtech realities produce your best odds of success.
Perfect for:Companies ready to pursue an early exit and want experienced deal leadership to handle the process.
The Success Story That Started It All
Clarify Your Company’s Strategic Exit Options
Thoughtful exit planning ensures founders and boards make decisions with clarity, control, and optionality. Evaluate buyer alignment, timing, and strategic priorities before critical milestones arrive.
Newsletter: Small Ball Strategies for Medtech Early Exits Via M&A
Strategies, tactics, and tips to help you lead your medical device startup or SMB to a successful, profitable, and durable equity/asset sale or partnership